z-logo
open-access-imgOpen Access
Proxy-Reported Quality of Life and Access to Nusinersen Among Patients with Spinal Muscular Atrophy in Saudi Arabia
Author(s) -
Yazed AlRuthia,
Ghadah S. Almuaythir,
Hala Alrasheed,
Wejdan R. Alsharif,
Mohamad-Hani Temsah,
Fahad Alsohime,
Ibrahim Sales,
Fahad A. Bashiri
Publication year - 2021
Publication title -
patient preference and adherence
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.885
H-Index - 48
ISSN - 1177-889X
DOI - 10.2147/ppa.s305849
Subject(s) - sma* , medicine , spinal muscular atrophy , visual analogue scale , quality of life (healthcare) , physical therapy , pediatrics , surgery , disease , nursing , mathematics , combinatorics
The recent approval of innovative therapies for spinal muscular atrophy (SMA), such as nusinersen, has brought hope to patients and their families.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here